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Despite recent advances in delineating the
mechanisms involved in cardiogenesis, cellular
lineage specification remains incompletely un-
derstood. To explore the relationship between
developmental fate and potential, we isolated
a cardiac-specific Nkx2.5+ cell population from
the developing mouse embryo. The majority of
these cells differentiated into cardiomyocytes
and conduction system cells. Some, surpris-
ingly, adoptedasmoothmuscle fate. Toaddress
the clonal origin of these lineages, we isolated
Nkx2.5+ cells from in vitro differentiated murine
embryonic stem cells and found 28% of these
cells expressed c-kit. These c-kit+ cells pos-
sessed the capacity for long-term in vitro expan-
sion and differentiation into both cardiomyo-
cytes and smooth muscle cells from a single
cell. We confirmed these findings by isolating
c-kit+Nkx2.5+ cells from mouse embryos and
demonstrated their capacity for bipotential dif-
ferentiation in vivo. Taken together, these results
support theexistenceofacommonprecursor for
cardiovascular lineages in themammalian heart.
INTRODUCTION
The mammalian heart develops through a series of care-
fully orchestrated events and contains three major line-Cellages—myocardial, endothelial, and smooth muscle cells.
The developmental precursor for myocardial cells is most
commonly ascribed to the cardiogenic mesoderm arising
from cells in the primitive streak (Garcia-Martinez and
Schoenwolf, 1993; Hatada and Stern, 1994). These cells
migrate bilaterally into the anterolateral mesoderm to
form the primary heart field, adopt a crescent shape,
and fuse at the midline to produce a linear heart tube com-
posed of an outer epithelial myocardium and an inner
endothelium (Rosenquist and DeHaan, 1966; Srivastava
and Olson, 2000). Subsequent morphogenetic events
give rise to a mature four-chambered heart.
The origin of the endocardium is unclear. Earlier studies
in chick support the existence of distinct progenitor cell
populations within the primitive streak for myocardium
and endocardium prior to their migration into the cardio-
genic mesoderm (Coffin and Poole, 1988). More recent
studies on gene expression and differentiation potential
of mesodermal explants point to the existence of a bipo-
tential precursor cell (Eisenberg and Bader, 1995). Using
a retroviral labeling technique to tag single cells in early
mesoderm, Cohen-Gould and Mikawa found no simulta-
neously labeled endocardial and myocardial cells at the
linear heart tube stage (Cohen-Gould and Mikawa,
1996). Taken together, these studies support an early sep-
aration of endocardial and myocardial lineages in the
developing chick heart, most likely prior to or during gas-
trulation. It remains to be seen whether early separation of
these lineages occurs in the mouse embryo.
The embryonic development of vascular smooth mus-
cle cells takes place later than that of myocardial or endo-
cardial cells. As such, diverse tissue sources have been
described to give rise to smooth muscle cells in different127, 1137–1150, December 15, 2006 ª2006 Elsevier Inc. 1137
organs (Stavros and Majesky, 1996). For example, aortic
smooth muscle cells have dual origins in the neural crest
and the lateral plate mesoderm (Le Lievre and Le Douarin,
1975; Waldo and Kirby, 1993; Hungerford et al., 1996). The
proepicardial organ, a dorsomesodermal structure, gives
rise to the epicardium, a tissue that undergoes epithelial-
to-mesenchymal transformation to generate the endothe-
lial and smooth muscle cells of the coronary arteries
(Mikawa and Gourdie, 1996). It appears that smooth mus-
cle cells have a less distinct developmental origin in gen-
eral and are recruited locally from mesenchymal precur-
sors and differentiate in response to specific tissue signals.
While these pioneering studies provide a conceptual
framework for understanding the relative contributions to
cardiac morphogenesis by cells of distinct origin, recent
investigations suggest multipotential progenitors exist for
cells of the mesodermal lineage. Using rare recombination
events to genetically mark single cells in the developing
embryo, Esner et al. have demonstrated a common pre-
cursor for skeletal muscle and aortic smooth muscle cells
(Esner et al., 2005). Similarly, cells of the cranial pharyngeal
mesoderm, a population that normally gives rise to head
musculature, can contribute to the developing cardiac out-
flow tract (Tirosh-Finkel et al., 2006). Moreover, progenitor
cells capable of differentiating into endothelial and smooth
muscle cells have recently been described (Ema et al.,
2003). Detailed lineage analyses of smooth muscle cells
at the base of aorta and pulmonary artery have revealed
an unexpected origin from the secondary heart field, a re-
cently described cell population arising dorsomedial to the
primary heart field and thought to give rise to only the myo-
cardium of the outflow tract, right ventricle, and ventricular
septum (Verzi et al., 2005; Waldo et al., 2005). Further-
more, these vascular smooth muscle cell progenitors
express Nkx2.5, a lineage marker associated with myo-
cardial progenitor cells. Indeed, lineage analysis of the
progenies of Nkx2.5+ cells using locus-specific Cre re-
combinase approaches revealed that multiple cell types
(including outflow tract smooth muscle cells and yolk sac
endothelial cells) express this gene (Moses et al., 2001;
Stanley et al., 2002). Taken together, these studies raise
the possibility that developmental multipotentiality is
more pervasive than previously expected. None of these
studies, however, attempted to define the identity of these
putative progenitor cells by prospectively isolating and
characterizing their multilineage differentiation.
To investigate the relationship between developmental
fate and potential of embryonic cardiac progenitor cells,
we isolated early Nkx2.5-expressing cells from the devel-
oping mouse heart and demonstrated their differentiation
into both beating cardiomyocytes and smooth muscle
cells. To address whether bipotential differentiation oc-
curred at a single cell level, we isolated Nkx2.5+ cells
from in vitro differentiated embryonic stem (ES) cells and
showed that a c-kit+ subpopulation harbors enhanced ca-
pacity for in vitro expansion and bipotential differentiation
from a single cell. To explore these ES cell-based findings
in an embryological context, we isolated c-kit+ Nkx2.5+1138 Cell 127, 1137–1150, December 15, 2006 ª2006 Elsevier Icells from the developing mouse embryo and demon-
strated their ability to undergo both myocardial and
smooth muscle cell differentiation in vivo. Taken together,
these data support the divergence of smooth muscle and
myocardial lineages from a common cardiovascular pre-
cursor in the developing heart field.
RESULTS
Generation of Cardiac-Specific Nkx2.5-eGFP
Transgenic Mice
Nkx2.5 is one of the earliest cardiac transcription factors
expressed in the developing heart field. The expression
domain of murine Nkx2.5, however, encompasses many
tissues, including the thyroid, pharynx, stomach, and
spleen (Moses et al., 2001). To achieve cardiac-specific
eGFP expression, we utilized a 2.1 kb enhancer located
9.5 kb upstream of the translation start site of murine
Nkx2.5 (Lien et al., 1999) along with a 500 bp Nkx2.5
base promoter to generate transgenic mouse lines
expressing eGFP specifically in the developing heart
(Figure 1A).
eGFP Expression in Nkx2.5-eGFP Transgenic Mice
The expression of eGFP in embryonic day 7.5 (E7.5) cells
could only be observed by flow cytometry (data not shown)
but not by whole mount fluorescence microscopy
(Figure 1B). This expression, however, was easily detect-
able from E8.5 until E11.5 (Figure 1B). Immunohistochem-
ical analysis revealed the presence of eGFP+ cells pre-
cisely in the myocardial layer (M) but not the endocardial
(E) layers (Figure 1C, b0 and f0 insets). At E8.5, the expres-
sion of eGFP (Figure 1C, b0 inset) overlapped partially with
that of isl1 (Figure 1C, c0 and inset with arrows), which
marks exclusively progenitor cells for the secondary heart
field (Cai et al., 2003). eGFP expression overlapped com-
pletely with sarcomeric myosin heavy chain (Sarc. MHC)
(Figure 1C, d0), an early myocardial marker in the primary
heart field. At E10.5, a minor cell population in the outflow
tract (OFT) beyond the endocardial cushion (EC) coex-
presses Nkx2.5 (via eGFP) (Figure 1C, i0) and isl1
(Figure 1C, j0 and inset). The expression of isl1, however,
is found predominantly in the dorsomesocardium and the
neural crest at E9.5 in a nonoverlapping manner with
Nkx2.5 (Figure S1, E9.5 isl1 and inset). The low number
of coexpressed isl1+ and Nkx2.5+ cells can be explained
by the fact that Nkx2.5+ cells here are mostly derivatives
of the primary heart field or that isl1 expression may have
declined prior the onset of Nkx2.5 expression in the sec-
ondary heart field (Cai et al., 2003; Laugwitz et al., 2005).
Interestingly, coexpression of early myocardial (Sarc.
MHC) and smooth muscle (smooth muscle actin-
a [SMAa]) markers were found in looping heart tube at
E9.5 (Figure S1). The expression of definitive myocardial
genes such as cardiac troponin T (cTnT) was absent at
these stages of cardiac development (Figure 1C, g0) and
appeared only after E11.5 (Figure S1, E11.5). Likewise, ex-
pression of the definitive marker for smooth musclenc.
Figure 1. Analysis of Nkx2.5-eGFP Expression in Transgenic Embryos
(A) Construct diagram for the Nkx2.5 cardiac enhancer-eGFP plasmid (upper panel). Founder number 3 (asterisk), carrying the 260 bp transgene PCR
product, was propagated (lower panel). Std, molecular weight standard; V, Nkx2.5-eGFP vector; C, positive tail control for transgene; W, H2O
negative control.
(B) Whole mount fluorescence analysis of eGFP expression in E7.5–E11.5 embryos. Bar, 1 mm.
(C) Immunohistochemical analysis of eGFP expression in serial sections of E8.5–E10.5 embryos. The expression of eGFP (black stain) at E8.5 (a0, b0),
E9.5 (e0, f0, inset), and E10.5 (h0, i0) is restricted to the myocardial layer (indicated by M in b0 and f0 inset) but not the endocardial layer (indiated by E in
b0 and f0 inset). Isl1 (c0 and inset, j0 and inset) (nuclear black stain), sarcomeric MHC (d0) (brown stain), cTnT (g0), sarcomeric actinin (k0).
(D) Flow cytometric analysis of dissected and collagenase treated E9.5 transgenic mouse heart cells. Compared with wild type, 63% of the transgenic
heart cells were eGFP+.
(E) Analysis of the percentage of eGFP+ cells in the developing heart. Each bar represents mean of six eGFP+ hearts.Cell 127, 1137–1150, December 15, 2006 ª2006 Elsevier Inc. 1139
lineage, smooth muscle myosin heavy chain (SM-MHC),
was absent in myocardial cells at E9.5 and initiated in vas-
cular smooth muscle cells of the thoracic cavity at E11.5
(Figure S1). The expression of eGFP diminished by
E11.5 during myocardial maturation, in contrast with the
expression of endogenous Nkx2.5 that is sustained
throughout cardiac development (Lien et al., 1999). Anal-
ysis of E9.5 heart cells by flow cytometry showed a range
of eGFP expression levels within each heart, consistent
with the presence of a mixed population of progenitor cells
and differentiating cardiomyocytes (Figure 1D). The per-
centage of eGFP+ heart cells also decreases from E8.5
to E15.5 (Figure 1E). It appears that the expression of
eGFP directed by this Nkx2.5 cardiac enhancer is specific
for cells at the progenitor stage of development.
Differentiation Potential of Nkx2.5+ Cells
from the Embryonic Heart
To assess the potential of Nkx2.5+ cells to spontaneously
differentiate into chamber-specific myocytes and conduc-
tion system, we isolated eGFP+ cells from E9.5 transgenic
hearts by fluorescence-activated cell sorting (FACS) and
cultured them in vitro. As expected, greater than 87% of
these cells differentiated into cardiomyocytes and con-
duction system cells (Figure 2A and Video S1). Electro-
physiological analysis at a single-cell level confirmed their
maturation into conduction system cells as well as atrial
and ventricular myocytes (Figure 2A). We observed that
92% ± 4% of the eGFP+ cells survived the sorting proce-
dure. Of these, 12% were immature in appearance (ar-
rows) and formed clusters when plated at low density
(Figure 2B). Within these clusters, some cells differenti-
ated into beating cardiomyocytes (arrowheads) and vas-
cular smooth muscle cells (asterisks). The expression of
differentiated myocardial (cTnT) and smooth muscle cell
(SM-MHC) markers was detected by immunofluores-
cence microscopy (Figure 2C). Quantitatively, cells within
each cluster possessed modest capacity for spontaneous
differentiation in vitro into either myocardial (9.4%) or
smooth muscle (15.3%) lineages (Figure 2D). The expres-
sion of endothelial cell markers (Flk1 and Tie-2) was not
observed (data not shown), supporting an early separation
of endothelial and myogenic lineages.
The capacity for the Nkx2.5+ cells to undergo smooth
muscle differentiation suggests either common expres-
sion of Nkx2.5 in two distinct lineages or the existence
of a common progenitor for both cell types. To ascertain
whether a single cell can undergo bipotential differentia-
tion into both myocardial and smooth muscle cells, we
dissected E7.5 and 8.5 mouse embryos and deposited
FACS-purified single eGFP+ cells into individual wells
of a 96-well plate. However, we were unable to induce
expansion or terminal differentiation of these cells at
single-cell density despite repeated attempts.
Derivation of Nkx2.5-eGFP ES Cell Line
As an alternative approach, we isolated Nkx2.5-eGFP+
cells from in vitro differentiated ES cells to address1140 Cell 127, 1137–1150, December 15, 2006 ª2006 Elsevier Iwhether clonal differentiation into myocardial and smooth
muscle cell lineages can occur from a single progenitor
cell. ES cells can differentiate upon withdrawal of leuke-
mia inhibitor factor to express lineage markers in a tem-
poral pattern similar to that of the developing embryo
(Figure 3A).
To generate an Nkx2.5-eGFP ES cell line, we introduced
the Nkx2.5 cardiac enhancer-eGFP transgene into CJ7 ES
cells and selected transgenic clones that expressed eGFP
specifically in beating cell clusters at day 9 of differentia-
tion (Figure 3B and Video S2). To confirm the cardiac
specificity of eGFP expression in vivo, ES cell clones
were introduced into E3.5 blastocysts to generate E10.5
chimeric embryos. These embryos express eGFP exclu-
sively in the developing outflow tract and common ventri-
cle (Figure S2A) mirroring that of the transgenic mice
(Figure 1B).
Differentiation of ES Cell-Derived Nkx2.5+ Progenitor
Cells In Vitro and In Vivo
To assess the identity of these eGFP+ cells, eGFP+ and
eGFP cells were segregated by FACS from day 5 in vitro
differentiation transgenic ES cells (Figure 3C, middle
panel). The purity of the sorted eGFP+ cells was confirmed
by reanalysis of the eGFP+ population (>93%) (Figure 3C,
right panel). The segregation of cardiac from noncardiac
cells was supported by expression analysis of lineage
markers within each sorted population (Figure 3D). As ex-
pected, the expression of markers for noncardiovascular
lineages (e.g., hematopoietic and skeletal muscle) was
found predominantly in the eGFP subpopulation. Consis-
tent with this, eGFP+ cells also preferentially differentiated
into cardiomyocytes, as assessed by the presence of
beating cell clusters (Figure 3E). Furthermore, the commit-
ment of these eGFP+ cells into a cardiogenic fate was sup-
ported by the inability of growth factor supplementation to
direct these cells into neuronal, hematopoietic, or skeletal
muscle fates when compared with undifferentiated ES
cells (Figure S2B). These eGFP+ cells exhibited high ca-
pacity for in vitro expansion as demonstrated by their
ability to undergo >90 passages in culture. Analysis of
the progeny of eGFP+ progenitors by immunocytochemis-
try confirmed the presence of both cardiomyocytes and
smooth muscle cells (Figure 3F).
To investigate the commitment of eGFP+ cells for myo-
genic differentiation in vivo, we injected FACS-purified
eGFP+ cells from day 5 in vitro differentiated ES cells into
the hindlimbs of syngeneic mice (1 3 106 cells/limb; N =
15) to achieve stable engraftment (Figure 4A). Control in-
jections using undifferentiated transgenic ES cells (1 3
106 cells/limb, N = 5) were performed in parallel. As ex-
pected, undifferentiated ES cell-injected limbs formed pro-
gressively enlarging teratomas at 7, 21, and 35 days post-
injection (Figure 4B). These teratomas were comprised
of cells from all three germ layers, including neurons, glan-
dular epithelia, blood, bone, and trachea. Injection of
eGFP+ cells failed to generate teratomas (0 of 15). Instead,
they infiltrated existing skeletal muscle bundles at day 7nc.
Figure 2. In Vitro Differentiation of Embryonic Nkx2.5-eGFP+ Cells
(A) Myocardial differentiation of FACS purified E9.5 eGFP+ cells. The morphologies of the differentiated progenies were assessed 8 days after sorting
(left panel). Spontaneous action potentials are also shown (right panel).
(B) A representative eGFP+ progenitor cell cluster. Progenitor cells, arrows; cardiomyocytes, arrowheads; and smooth muscle cells, asterisks.
(C) Immunofluorescence microscopy of eGFP+ cells. Cardiac troponin T, cTnT; smooth muscle myosin heavy chain, SM-MHC; and smooth muscle
actin-a, SMAa. Cell nuclei were counterstained with DAPI.
(D) Myocardial versus smooth muscle cell differentiation of eGFP+ progenitor cells. Cardiomyocytes (CMC) or smooth muscle cell (SMC) differenti-
ation was assessed by immunofluorescence staining for cTnT or SM-MHC, respectively. Progenitor cells were defined by the absence of cTnT or
SM-MHC staining. Each bar represents means ± SEM of the percentage of cells that expressed the respective lineage marker from total DAPI+ cells.postinjection (Figure 4C, D7 arrows). At 35 days postinjec-
tion, sprouts of new myofibrils were found within areas of
cell injection (Figure 4C, D35 arrows). Immunohistochemi-
cal staining revealed the coexpression of eGFP with GATA-
4, cardiac MHC, and cTnT in some cells. The expression of
SMAa was also detected, but in a nonoverlapping pattern
with eGFP. This is more likely due to the downregulation of
eGFP expression in transplanted cells that have differenti-
ated towards smooth muscle lineage and not from the
detection of endogenous smooth muscle cells.
c-Kit Is a Marker for a Progenitor Cell Subpopulation
within Nkx2.5+ Cells
Since the expression of Nkx2.5 marks a mixture of pro-
genitors and immature myocytes, we sought to identify
surface markers that predict progenitor status within
Nkx2.5+ cells. We examined the expression of >30 surface
proteins using commercially available flow cytometryCell 1competent antibodies and found a modest level of c-kit
and Sca-1 expression, but no expression of endothelial
or hematopoietic lineage markers (Figure 5A). The expres-
sion levels of CD71 (transferrin receptor) and CD29 (integ-
rin b1) were high, but the expression of these markers
failed to correlate with progenitor cell status (data not
shown). We fractionated Nkx2.5+ cells based on their c-kit
expression and found that the c-kit+ cells appeared less
differentiated morphologically than c-kit cells (Figure 5B,
upper panels). Consistent with this, c-kit+ cells also pos-
sessed 40-fold greater capacity for proliferation than
c-kit cells (Figure 5B, lower left panel). c-Kit cells, on
the other hand, were more likely to form beating cardio-
myocytes (Figure 5B, lower right panel). The expression
of Sca-1 did not distinguish proliferating from differentiat-
ing cells (data not shown).
Using c-kit as a marker for a progenitor cell subpopula-
tion within Nkx2.5+ cells, we investigated the capacity for27, 1137–1150, December 15, 2006 ª2006 Elsevier Inc. 1141
Figure 3. Isolation of Nkx2.5+ Progenitor Cells from In Vitro Differentiated ES Cells
(A) Quantitative PCR analysis of developmental cardiac gene expression in differentiating ES cells. Expression of each gene was normalized to b-actin level.
(B) Schematic diagramfor cardiac-specific Nkx2.5-eGFP transgenicES cell line generation (upper panel). Three clones (numbers 74, 94, and 110) expressed
eGFP specifically in beating cell clusters (lower panels).
(C) Isolation of cardiac-specific Nkx2.5-eGFP+ cells by FACS. eGFP+ (blue gate) and eGFP (red gate) live cells were purified from in vitro differentiated ES
cells at days 5 or 6.
(D) Analysis of gene expression in eGFP+ and eGFP cells by RT-PCR. Qualitative PCR for the expression of cardiac (Nkx2.5, MLCv), smooth muscle
(SM-MHC), endothelial (PECAM), hematopoietic (GATA-1), or skeletal muscle (Myogenin, MyoD) genes in eGFP+ (G+), eGFP (G), or presort (Pre) cell
populations is shown. Hrt, adult heart tissue; Liv, adult liver tissue as negative control; Std, molecular weight standard.1142 Cell 127, 1137–1150, December 15, 2006 ª2006 Elsevier Inc.
Figure 4. In Vivo Differentiation of ES Cell-Derived Nkx2.5+ Cells
(A) Schematic diagram of transplantation of ES cell or eGFP+ cells into the hind limbs of syngeneic mice.
(B) Formation of teratomas in ES cell-injected limbs. Hind limbs were isolated on days 7 (D7), 21 (D21), and 35 (D35). Black bar, 50 mM.
(C) Formation of cardiac cells in eGFP+ cell-injected limbs. No teratoma (0/15) was found. Injected cells can be seen infiltrating existing skeletal mus-
cle bundles on day 7 (D7, arrows). On day 35 new myofibrils can be observed (D35, arrows). Immunohistochemical staining for eGFP, GATA-4,
cardiac MHC, cTnT, SMAa, and SM-MHC are also shown. Black bar, 50 mM.a single c-kit+Nkx2.5+ cell to differentiate into both myo-
cardial and smooth muscle lineages. c-Kit+Nkx2.5+ single
cells were plated into each well of 96-well plates on day
0 and cultured in vitro until day 13 (Figure 5C). Approxi-
mately 5% of 672 plated cells survived single cell cloning.
Examination of cells within each well on day 13 revealed
three distinct patterns of differentiation. Approximately
42% of the single cell clones differentiated into beating
cardiomyocytes (clones 1–13) and expressed a-cardiac
actin and ventricular myosin light chain (MLCv) (Figure 5D,
blue bars). Thirty-two percent differentiated into cells ex-
pressing smooth muscle markers, SM22a and SMAa,
and failed to beat spontaneously (clones 22–31) (Fig-
ure 5D, red bars). The remaining wells (clones 14–20) con-
tained both beating cardiomyocytes and vascular smooth
muscle cells, confirming their bipotential differentiation
from a single cell (Figures 5C and 5D and Video S3).
Identification of Bipotential c-Kit+Nkx2.5+ Progenitor
Cells in the Developing Embryo
The ES-cell studies above suggest that early Nkx2.5+
progenitors expressed c-kit. We investigated whether
c-kit+Nkx2.5+ cells are present in the developing heart
field in vivo. Flow cytometry analysis of embryonic
hearts from Nkx2.5-eGFP transgenic mice revealed thatCell 113% ± 6% of E8.5 eGFP+ cells express c-kit (Figure 6A).
This expression decreased with myocardial maturation,
such that by day15.5, c-kit expression was nearly unde-
tectable within the Nkx2.5+ population. The expression
of Sca-1 within eGFP+ cells appeared later at E13.5 and
increased with myocardial differentiation (Figure 6A).
To assess whether c-kit expression confers progenitor
cell status within Nkx2.5+ cells, we separated E8.5
eGFP+ cells based on their level of c-kit expression and an-
alyzed their cell morphology and differentiation status by
quantitative and qualitative PCR. As shown in Figure 6B,
c-kit+ cells appeared to be morphologically less differenti-
ated compared with c-kit cells. Gene expression analysis
confirmed that c-kit cells were more differentiated and
preferentially expressed myocardial and smooth muscle
lineage markers compared with c-kit+ cells (Figure 6C).
These c-kit+ cells are unlikely to originate from hematopoi-
etic sources, as blood-forming cells have not entered the
heart tube at this stage of embryonic development. To de-
termine the role of Sca-1 expression, we fractionated
E15.5 eGFP+ heart cells based on their Sca-1 status. We
found the expression of Sca-1 did not predict progenitor
cell status within eGFP+ cells (Figure S3A).
The expression of c-kit in eGFP+ cells was further con-
firmed by immunofluorescence analysis of frozen sections(E) Formation of beating cell clusters by FACS-purified eGFP+ cells.
(F) Immunocytochemical analysis of differentiated eGFP+ cells. Sarcomeric MHC, Sarc MHC; cardiac troponin T, cTnT, sarcomeric actinin, Sarc. Actinin;
smooth muscle actin-a, SMAa; control IgG, IgG. The SMAa+ cells were found to occasionally self-assemble into tubular structures in vitro (lower right panel).27, 1137–1150, December 15, 2006 ª2006 Elsevier Inc. 1143
Figure 5. Identification of a c-Kit+ Subpopulation as Progenitor Cells within eGFP+ Cells
(A) Expression of selected surface markers by Nkx2.5-eGFP+ cells.
(B) Differential capacity for proliferation and differentiation of FACS-purified eGFP+c-kit+ versus eGFP+c-kit cells from day 5 in vitro differentiated ES
cells. The morphologies of c-kit+ and c-kit sorted cells are shown (upper panels). The total number of cells in culture at days 6 and 12 after isolation is
displayed in lower left panel. The number of beating cell clusters formed was assessed on day 12 (lower right panel).
(C) Clonal differentiation of eGFP+c-kit+ single cells. eGFP+c-kit+ cells from day 5 in vitro differentiated ES cells were deposited as single cells into
each well of a 96-well plate. At day 13, the presence of beating cell cluster (demarcated by dashed white line) and the expression of SMAa (by
immunofluorescence) were assessed.
(D) Quantitative PCR analysis of differentiated progenies from each c-kit+Nkx2.5+ single-cell clone. The b-actin adjusted expression of a-cardiac actin
(blue bar) and SM22a (pink bar) (top panel), MLCv (blue bar), and SMAa (red bar) (bottom panel) in each well is shown.from E9.5 and E10.5 hearts (Figure S3B). Interestingly,
c-kit+Nkx2.5+ cells localized in the outer layer of compact
myocardium, suggesting that the niche for these develop-
ing progenitor cells is adjacent to the epicardium. This
observation is consistent with an essential role for epi-
cardial-secreted factors that stimulate myocardial cell pro-
liferation and expansion of the compact myocardial layer
(Lavine et al., 2005).
Bipotential Differentiation of c-Kit+Nkx2.5+
Progenitor Cells
We postulated that smooth muscle cell differentiation from
a common progenitorcell results in analterationof itsmolec-
ular phenotype from that of differentiating myocardial cells.1144 Cell 127, 1137–1150, December 15, 2006 ª2006 ElsevierTo test whether thecontinued expression ofeGFP could dis-
tinguish myocardial from smooth muscle cells, we isolated
eGFP+ cells from E9.5 Nkx2.5-eGFP transgenic mouse
hearts and allowed them to undergo spontaneous differen-
tiation in vitro (Figure 6D, a0). Following 3 days of culture, we
separated cells that continued to express eGFP from cells
that became eGFP and analyzed their gene expression.
We observed a clear segregation of myocardial lineage
markers into the eGFP+ population and smooth muscle
markers into the eGFPpopulation (Figure6D,b0).The main-
tenance of Nkx2.5 expression appeared to characterize
myocardial differentiation from a bipotent-progenitor cell.
To establish whether c-kit+Nkx2.5+ cells can undergo
bipotential differentiation in vivo, we employed aInc.
well-established chick xenograft transplantation assay
and injected freshly isolated c-kit+eGFP+ heart cells
(2500 cells/heart) from E9.5 Nkx2.5-eGFP/ROSA-LacZ
double-heterozygous mouse embryos into each of stages
8–13 chick embryos (Figure 6E) (N = 15). One of five surviv-
ing embryos demonstrated engraftment of transplanted
cells at the aortic arch/ branchial vessel region. Immuno-
histochemical analysis revealed smooth muscle cell differ-
entiation and integration of LacZ+ cells into an existing
blood vessel (Figure 6E, a0–d0). Myocardial differentiation
occurred as well (Figure 6E, e0–g 0), but these cells
appeared unable to integrate into chick myocardium, pre-
sumably due to their ectopic site of engraftment.
DISCUSSION
In this paper, we explored the developmental progression
from precardiac mesoderm to myocardial commitment
using a genetic tagging approach that allowed for the pro-
spective isolation of cardiac progenitor cells. Importantly,
we demonstrated that a c-kit+Nkx2.5+ population differen-
tiates spontaneously into both myocardial and smooth
muscle cells, as revealed by in vitro differentiation of ES
cells and by embryonic transplantation studies. These bi-
potent progenitors appear unable to form hematopoietic,
neuronal, or skeletal muscle cells; thus, they represent a
population that is restricted with respect to other lineages.
Taken together, these studies support a new paradigm for
cardiovascular development involving the divergence of
myocardial and smooth muscle cell lineages from a com-
mon precursor in the primordial heart field.
Relationship between Nkx2.5+ Cells
and other Embryonic Progenitor Cells
Prior lineage tracing studies in mice have demonstrated
diverse developmental origins for vascular smooth muscle
cells. In particular, the cardiac neural crest can give rise to
vascular smooth muscle cells of the aortic arch, as well as
of the coronary vessels (Le Lievre and Le Douarin, 1975;
Waldo and Kirby, 1993; Hungerford et al., 1996; Hutson
and Kirby, 2003; Stoller and Epstein, 2005). In addition,
cells from the secondary heart field have been shown to
generate cardiomyocytes of the outflow tract, as well as
vascular smooth muscle cells of the aortic ring (Verzi
et al., 2005; Waldo et al., 2005). The contribution of these
cells to multiple lineages suggests either a broad develop-
mental potential of a common precursor or the existence
of multiple lineage-committed progenitors at the same
anatomical site.
In this regard, it is of interest that Moretti et al. report the
identification of an isl1+ progenitor cell capable of multili-
neage differentiation in vitro into smooth muscle cells, car-
diomyocytes, as well as endothelial cells (Moretti et al.,
2006). The relationship between these isl1+ progenitors
and the c-kit+Nkx2.5+ cells that we have described herein
remains to be clarified. Given that cells of both the primary
and secondary heart fields express Nkx2.5, whereas isl1 is
expressed exclusively in the secondary heart field, the twoCell 1progenitor cell populations may either be completely
distinct (if c-kit+Nkx2.5+ cells are derived entirely from
the primary heart field) or related (if isl1-expressing cells
in the secondary heart field are descendents of the meso-
dermal c-kit+ cells). Of note, our analysis of E10.5 embryos
revealed eGFP+ cells in the outflow tract that colocalized
with isl1+ cells (Figure 1C, E10.5). These cells are located
in the secondary heart field in a region that Waldo et al.
had postulated as a site where a bipotential smooth mus-
cle and myocardial progenitor cell might arise (Waldo et al.,
2005). Further experiments using cells doubly marked for
isl1 and Nkx2.5 will help to rigorously define the relation-
ship between these populations.
Relationship between c-Kit+Nkx2.5+ Cells and c-Kit+
Cardiac Stem Cells
The adult c-kit+ cardiac stem cell is characterized by the ex-
pression of c-kit in the absence of lineage markers such as
Nkx2.5 (Beltrami et al., 2003). The developmental potential
of these adult c-kit+ cells also appears to be broader. These
c-kit+ cells may represent a developmental remnant from
a multipotent mesodermal cell population that has per-
sisted in the heart throughout embryonic and postnatal
development. Alternatively, these c-kit+ cells may be ‘‘itin-
erant’’ mesodermal remnants residing in the bone marrow
and are mobilized in response to myocardial injury. These
cells, although not specifically programmed for myocardial
differentiation, have been shown to improve cardiac func-
tion in a myocardial injury/reconstitution assay (Fazel
et al., 2006). Further studies will be required to determine
the ancestral relationship between the c-kit+Nkx2.5+ cells
described here and the adult c-kit+ cardiac stem cells.
During development, c-kit is likely dispensable for myo-
cardial or smooth muscle cell proliferation and differentia-
tion. Studies from spontaneous mutation of the W locus
revealed no essential role for c-kit in cardiovascular devel-
opment or hematopoietic stem-cell formation despite the
established role of this gene as a stem-cell marker (Reith
et al., 1990). We believe the expression of c-kit serves
as an indicator for developmental potential in different
organ systems and, in conjunction with Nkx2.5, defines
a bipotent population of cardiovascular progenitor cells.
The Existence of a Bipotential Myogenic Precursor
Cell Supports a New Developmental Paradigm for
Cardiogenesis
Our data support the existence of a common myocardial
and smooth muscle cell precursor in the developing em-
bryo. This is consistent with in vivo studies demonstrating
the coexpression of numerous smooth muscle genes in
myocardial progenitor cells (Figure S1) (Samaha et al.,
1996; Li et al., 1996; Jain et al., 1998). Although it has
been proposed that myocardial cells undergo a smooth
muscle cell-like transition during early development (Li
et al., 1996), we demonstrated that the coexpression of
myocardial and vascular smooth muscle cell markers rep-
resents evidence for the divergence of these two lineages
from a common myogenic precursor. In this regard, recent27, 1137–1150, December 15, 2006 ª2006 Elsevier Inc. 1145
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reports of common progenitor cells for paraxial skeletal
muscle cells and aortic smooth muscle cells (Esner et al.,
2005), head skeletal muscle and myocardial cells of the
outflow tract (Tirosh-Finkel et al., 2006), myocardial and
hematopoietic cells (Masino et al., 2004), and endothelial
and vascular smooth muscle cells (Ema et al., 2003), all
suggest that developmental multipotentiality is more prev-
alent than that supported by earlier studies. The common
myogenic precursor that we prospectively isolated and
characterized in this study points to a new paradigm of car-
diogenesis where a single multipotent stem/progenitor cell
contributes to cells of diverse lineages within the heart.
A Model for the Differentiation of Precardiac
Mesoderm into Cells of Divergent Fates
within the Heart
A model for the developmental progression from precar-
diac mesoderm to committed cardiovascular progenitor
cell prior to chamber-specific differentiation is depicted
in Figure 7. In this model the expression of c-kit precedes
the expression of Nkx2.5 at the precardiac mesoderm
stage. The initiation of Nkx2.5 expression denotes com-
mitment into a precursor for myocardial and smooth mus-
cle lineages. The expression of c-kit within Nkx2.5+ cells is
lost when these cells transition into either smooth muscle
or myocardial precursors. With further differentiation,
these precursor cells become atrial or ventricular-specific
myocytes or cells of the conduction system. Although not
specifically investigated in these studies, it has been
established that Purkinje fibers are derived from cardio-
myocyte precursors (Gourdie et al., 1995). Given that
Nkx2.5 mutation is responsible for conduction system dis-
ease in both mouse and human (Schott et al., 1998;
Pashmforoush et al., 2004), our ability to monitor the differ-
entiation of Nkx2.5+ progenitors into cells of the conduc-
tion system in vitro may provide unique insights into the
pathogenesis of cardiac arrhythmia.
In summary, we have established the existence of
a common myogenic precursor cell that gives rise to
both myocardial and smooth muscle lineages. This bipo-
tential progenitor cell makes a lineage choice decision atCell 1a single-cell level. These findings reveal a hierarchy for
myogenic differentiation in vivo and suggest a new devel-
opmental paradigm for cardiogenesis where a single multi-
potent progenitor cell gives rise to cells of diverse lineages
within the heart.
EXPERIMENTAL PROCEDURES
Generation of Nkx2.5-eGFP Transgenic Mice
A 2.1 kb enhancer fragment from the 50 regulatory region of murine
Nkx2.5 (Lien et al., 1999) (a kind gift from Dr. Eric Olson at UT South-
western, Dallas, TX) along with a 500 bp Nkx2.5 base promoter was
inserted into a promoterless eGFP expression vector (BD Biosci-
ences-Clontech, Mt. View, CA). The DNA insert, including the eGFP ex-
pression sequence, was introduced into the pronucleus from C57Bl/6
mice (Charles River Laboratories, Wilmington, MA). Of the initial
founders, one (number 3) was further expanded. All animal experiments
described in this paper have been approved by Animal Resources at
Children’s Hospital (ARCH) of Boston, MA.
Isolation and In Vitro Differentiation of Embryonic Nkx2.5+
Progenitor Cells
Embryos from timed matings of Nkx2.5-eGFP transgenic mice were
dissected to release their heart tubes. eGFP+ hearts were immediately
digested with collagenase solution (collagenase A [10 mg/mL] and B
[10 mg/mL] [Roche Diagnostics, Indianapolis, IN] in 10 mM HEPES
buffed saline [HBS] and 20% FCS) for 60 min at 37C. A single-cell sus-
pension was obtained by gentle triturition followed by passing through
a 40 mM cell strainer. eGFP+ and eGFP live cells (as defined by the
lack of propidium iodine [PI] staining) were isolated by FACS on a
MoFlo cell sorter (Cytomation Systems) and cultured in differentiation
medium (DM) containing IMDM with high glucose, 20% FCS, 5000 i.u./
mL penicillin/ streptomycin, 200 mM L-glutamine , 1-thioglycerol (1.5 3
104M), and ascorbid acid (50 mg/mL). Flow cytometry data was
acquired by CellQuestT v3.3 (BD Biosciences, San Jose, CA) and
processed using FlowJo v4.6.2 (Tree Star, Ashland, OR) software.
Generation of Nkx2.5-eGFP ES Cell Lines
The Nkx2.5 cardiac enhancer-eGFP plasmid was linearized and elec-
troporated into 11th passage CJ7 ES cells and cultured in the presence
of G418 to select for neomycin resistant colonies. A total of 168 colonies
were expanded and individually in vitro differentiated. Day 9 ES cell
aggregates (i.e., embryoid bodies [EBs]) were scored for their expres-
sion of eGFP by fluorescence microscopy. Three colonies (numbers
74, 94, and 110) showed complete correlation of eGFP expression
with beating cells. One line (number 74) was further studied.Figure 6. Isolation and Characterization of Nkx2.5+c-kit+ Cells from Developing Embryos
(A) Expression of c-kit (black bar) or Sca-1 (white bar) in eGFP+ cells during embryogenesis. Each bar represents mean ± SEM from four hearts.
(B) The morphologies of E8.5 eGFP+c-kit+ and eGFP+c-kit heart cells.
(C) Quantitative and qualitative PCR analysis of lineage marker expression in E8.5 eGFP+c-kit+ versus eGFP+c-kit cells. Bar graphs represent b-actin
adjusted fold overexpression by c-kit cells compared with c-kit+ cells. S, molecular weight standard; K+, c-kit+; K, c-kit; H, adult heart cells; and –,
H20 blank.
(D) Maintenance of eGFP expression distinguishes myocardial from smooth muscle cells in culture. eGFP+ cells from E9.5 hearts were cultured for 3
days and resegregated by FACS based on their continued expression of eGFP (panel a0 ). Quantitative and qualitative expression of myocardial and
smooth muscle markers are shown in panel b0. For myocardial lineage markers, bar graphs represent b-actin-adjusted fold overexpression by eGFP+
cells compared with eGFP cells. For smooth muscle lineage markers, bar graphs represent fold overexpression by eGFP cells compared with
eGFP+ cells. H, adult heart cells; –, H20 blank: G
+, eGFP+; G, eGFP; S, molecular weight standard.
(E) Transplantation of eGFP+c-kit+ cells from E9.5 ROSA-LacZ/Nkx2.5-eGFP transgenic mouse embryos into chick embryos. Tissues containing
LacZ+ cells (arrow in X-gal stained whole heart) were paraffin sectioned and counterstained with nuclear fast red (a0, b0, c0, e0). These same sections
were then stained with SMAa (d0), cTnT (f0 ), or control (IgG) (g0 ) antibodies, developed with DAB substrate, and counterstained with Hematoxylin Qs.
The arrows in (a0) and (e0) denote the major site of LacZ+ cell engraftment. Arrows in (c0 ) mark individual LacZ+ cells along a nearby blood vessel wall.
These same cells (red arrows in [d0]) also express SMAa (black stain). A cluster of LacZ+ cells (within dashed circle in [e0 ]) also express cTnT (dashed
red circle in [f0]).27, 1137–1150, December 15, 2006 ª2006 Elsevier Inc. 1147
Figure 7. Differentiation of Cardiovascular Lineages from a Common Precursor in the Precardiac Mesoderm
The expression of lineage markers shown is based on our current data as well as other published studies. The divergence of endothelial and hema-
topoietic lineages from myocardial lineage precedes the expression of Nkx2.5 in the precardiac mesoderm. BryT, brachyury T; VSMC, vascular
smooth muscle cell.In Vitro Differentiation of ES Cell-Derived Nkx2.5+ Cells
ES cells were cultured according to Fehling et al. (Fehling et al., 2003)
and adapted to gelatin-coated dishes in the presence of leukemia in-
hibitory factor for 2 days prior to differentiation. ES cell differentiation
was performed according to a previous published protocol (Wobus
et al., 1991). On the day of sorting, EBs were digested with either tryp-
sin/EDTA for 5 min or collagenase solution (if EBs were day 6 or later)
for 30 min. These cells were then resuspended in HBS with 20% FCS
and analyzed on a MoFlo cytometer. This treatment protocol resulted
in greater than 90% live single cells.
Immunohistochemical, Immunocytochemical,
and Immunofluorescence Analysis of Embryonic
and ES Cell-Derived Cells
Nkx2.5-eGFP transgenic mouse embryos or ES cell-injected mouse
hind limbs were fixed in 4% paraformaldehyde in phosphate buffered
saline and embedded in paraffin prior to 5 mM sectioning or in OCT
compound prior to 10 mM cryo-sectioning. Immunohistochemical
analysis was performed as previously described (Li et al., 2005).
Molecular Analysis of Gene Expression by Qualitative
or Quantitative PCR
Sorted cells from embryonic hearts or in vitro differentiated ES cells
were immediately added to Trizol reagent (Invitrogen, Carlsbad,1148 Cell 127, 1137–1150, December 15, 2006 ª2006 Elsevier ICA) and stored at 80 C until processed. Total RNA from each
sample was purified from cell lysate using the SV Total RNA kit (Prom-
ega, Madison, WI) according to manufacturer’s suggested protocol.
Qualitative and quantitative PCR were performed on cDNA made
from reverse transcribed RNA using the I-script cDNA synthesis
kit (BioRad, Hercules, CA) for total cell number >100,000, or Cells-
Direct cDNA synthesis system (Invitrogen, Carlsbad, CA) for cell
number less than 100,000. Qualitative RT-PCR was performed using
Taq polymerase (Roche Diagnostics, Indianapolis, IN) within the lin-
ear range of amplification (25–33 cycles) for each primer. Quantita-
tive PCR was performed using the I-cycler system with SYBR
Green substrate (BioRad, Hercules, CA) for 40 cycles. Primers
sequences used for qualitative and quantitative PCR are available
by request.
Mouse Hind-Limb Cell Transplantation Assay
Undifferentiated Nkx2.5-eGFP transgenic ES cells (N = 5) or FACS-
isolated eGFP+ cells (N = 15) from day 5 in vitro differentiated
Nkx2.5-eGFP transgenic ES cells were injected into the quadriceps
of anesthesized SV129 syngeneic mice (1 3 106 cells per injection).
At days 7, 21, and 35 (N = 5 each), mice were sacrificed and their
quadriceps harvested and fixed immediately in Bouin’s solution before
paraffin embedding and sectioning.nc.
Electrophysiological Studies of Differentiated Cardiomyocytes
FACS-purified Nkx2.5-eGFP+ cells from embryonic hearts were cul-
tured in DM for 8 days. During experiment, cells were bathed in extra-
cellular solution containing 140 mM NaCl, 2.8 mM KCl, 2 mM CaCl2,
2 mM MgCl2, 10 mM HEPES, and 10 mM glucose at pH 7.4. Patch
electrodes were filled with an intracellular solution containing140 mM
potassium gluconate, 10 mM NaCl, 2 mM MgCl2, 10 mM HEPES,
1 mM EGTA, 4 mM Mg-ATP, and 0.3 mM Na-GTP at pH 7.3, giving re-
sistances of 2–5 MU. Spontaneous cardiomyocyte action potentials
were recorded at room temperature using the whole-cell patch clamp
method in current clamp mode with an Axopatch 200A amplifier (Axon
Instruments/Molecular Devices, Sunnyvale, CA). Holding currents
were sometimes applied to alter the frequency of firing. Recorded
data were filtered online at 2 kHz, sampled, and digitized at 10 kHz
(Digidata 1322A and pClamp 9.2 software; Axon Instruments/Molecu-
lar Devices, Sunnyvale, CA).
Chick Embryo Transplantation Assay
FACS-purified eGFP+c-kit+ cells from E9.5 heart tubes of mice carry-
ing a b-galactosidase expressing transgene at the ROSA locus
(Gt(ROSA26) Sor, Jackson Lab, Bar Harbor, ME) (ROSA-LacZ) and
the Nkx2.5-eGFP transgene were transplanted into the anterolateral
plate mesoderm region of stage 8 or dorsomesocardial region of stage
13 chick embryos. At stage 35, the heart and aortic arch region of chick
embryos were harvested and fixed in 4% PFA for 15 min followed by
X-gal staining overnight. LacZ+ tissues were paraffin sectioned and
analyzed by nuclear counterstain and immunohistochemistry.
Supplemental Data
Supplemental data include Supplemental Experimental Procedures,
three figures, and three videos and can be found with this article online
at http://www.cell.com/cgi/content/full/127/6/1137/DC1/.
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